MAPT and neurodegenerative disease: JDPs have previously been implicated in various neurodegenerative diseases, with prior work suggesting that DnaJA2, DnaJB1, and DnaJB4 suppress tau aggregation in vitro (Nachman et al., 2020; Irwin et al., 2021).